McKesson Corporation
Key Metrics
How this company measures up on the fundamentals that matter
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Ethical Screening
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Valuation
Trading at $760, 26% above fair value of $604. Passes all ethical screens. Ranks better than 56% of screened stocks.
Quantitative Intelligence
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Market Data
Trading characteristics and market positioning
Financial Health
Balance sheet strength and cash generation — the foundation of long-term value
Analyst Coverage
Recent Insider Activity
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | VITALONE BRITT J | Chief Financial Officer | 8,979 | — | |
| 2026-05-19 | RODGERS THOMAS L | Officer | 3,614 | — | |
| 2026-05-19 | RUTLEDGE NAPOLEON B JR | Officer | 788 | — | |
| 2026-05-19 | LAU MICHELE | Officer | 4,454 | — | |
| 2026-05-19 | SMITH LEANN B | Officer | 4,129 | — | |
| 2026-05-19 | FRAGA FRANCISCO | Chief Technology Officer | 3,127 | — | |
| 2026-03-02 | LAU MICHELE | Officer | 2,725 | $2,697,750 | |
| 2026-02-19 | MARTINEZ MARIA N. | Director | 349 | $328,013 | |
| 2026-02-17 | SMITH LEANN B | Officer | 190 | $179,550 | |
| 2026-02-11 | LAU MICHELE | Officer | 303 | $282,817 |
Political Trading Activity
Congressional trading disclosures involving this instrument
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 6 May2026 | Scott Peters | Democrat | buy | 50K–100K |
| 15 May2026 | Ro Khanna | Democrat | sell | 15K–50K |
| 1 May2026 | Ro Khanna | Democrat | sell | 1K–15K |
What If You'd Bought MCK?
| Period | Price Then | Price Return | Divs/Share | $1,000 Became | Total Return |
|---|---|---|---|---|---|
| 1 Month | $724.37 | +8.9% | $0.82 | $1,090 | +9.0% |
| 2 Months | $864.64 | -8.8% | $0.82 | $913 | -8.7% |
| 3 Months | $943.32 | -16.4% | $0.82 | $837 | -16.3% |
| 6 Months | $813.96 | -3.1% | $1.64 | $971 | -2.9% |
| 1 Year | $702.00 | +12.4% | $3.28 | $1,128 | +12.8% |
| 2 Years | $586.24 | +34.5% | $6.12 | $1,356 | +35.6% |
| 3 Years | $388.56 | +103.0% | $8.60 | $2,052 | +105.2% |
| 5 Years | $190.28 | +314.5% | $12.64 | $4,211 | +321.1% |
Historical returns. Past performance does not guarantee future results. Prices from market close data.
Framework Review History
Timestamped framework reads — tracking how the analysis evolves over time
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials (87). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with strong ethical credentials (87). The risk-adjusted return profile shows good risk-adjusted returns.
Latest Analysis — MCK
Timestamped intelligence from our daily research pipeline
12 June 2026 • Alpha Insights Sector Research Top 50 Utility Stocks Ranked: Power, Water, and Renewable Energy AI data centre demand is rewriting the utility investment thesis. Constellation Energy’s...
12 June 2026 • Alpha Insights Sector Research Top 50 Industrial Stocks Ranked: Aerospace, Manufacturing, and Infrastructure Scored for Quality and Ethics Defence budgets are expanding globally, infrastructure spending bills...
12 June 2026 • Alpha Insights Sector Research Top 50 Healthcare Stocks Ranked: Pharma, Biotech, and MedTech Scored for Quality and Ethics Healthcare has become the quiet defensive rotation of...
.ai-post { background: #0a0e14; color: #e8e8e8; font-family: 'Inter', sans-serif; max-width: 860px; margin: 0 auto; padding: 32px 24px; } .ai-post h1 { color: #D8AF44; font-size: 2rem; line-height: 1.2; margin-bottom: 8px; }...
.ai-post { background: #0a0e14; color: #e8e8e8; font-family: 'Inter', sans-serif; max-width: 860px; margin: 0 auto; padding: 32px 24px; } .ai-post h1 { color: #D8AF44; font-size: 2rem; line-height: 1.2; margin-bottom: 8px; }...
.ai-post { background: #0a0e14; color: #e8e8e8; font-family: 'Inter', sans-serif; max-width: 860px; margin: 0 auto; padding: 32px 24px; } .ai-post h1 { color: #D8AF44; font-size: 2rem; line-height: 1.2; margin-bottom: 8px; }...
Graham, Buffett, and the Quran: The Surprising Alignment Between Value Investing and Islamic Finance By the Titan Protect Research Team Key Takeaways Shared Philosophy: Both classical value investing and Islamic...
Does Halal Investing Sacrifice Returns? The Data Says No Key Takeaways Feature Description Outperformance The Titan Ethical 500 returned +35.8% vs. +31.7% for the S&P 500 over 12 months. Lower...
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15